Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srivalli Telikepalli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|June 19, 2019
Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in BiopharmaceuticalsSrivalli Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, et al.
Journal of Pharmaceutical Sciences|February 18, 2017
Variable Threshold Method for Determining the Boundaries of Imaged Subvisible ParticlesRichard E Cavicchi, Cayla Collett, Srivalli Telikepalli, et al.
Analytical and Bioanalytical Chemistry|February 12, 2018
Development of orthogonal NISTmAb size heterogeneity control methodsAbigail Turner, Katharina Yandrofski, Srivalli Telikepalli, et al.
Analytical and Bioanalytical Chemistry|February 8, 2018
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stabilityJohn E Schiel, Abby Turner, Trina Mouchahoir, et al.
Journal of Pharmaceutical Sciences|December 19, 2014
Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stressSrivalli Telikepalli, Ozan S Kumru, Jae Hyun Kim, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sortingSrivalli Telikepalli, Heather E Shinogle, Prem S Thapa, et al.
Journal of Pharmaceutical Sciences|January 14, 2020
Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in JapanAkiko Ishii-Watabe, Hiroko Shibata, Hiroyuki Suetomo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|June 19, 2019
Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in BiopharmaceuticalsSrivalli Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, et al.
Journal of Pharmaceutical Sciences|February 18, 2017
Variable Threshold Method for Determining the Boundaries of Imaged Subvisible ParticlesRichard E Cavicchi, Cayla Collett, Srivalli Telikepalli, et al.
Analytical and Bioanalytical Chemistry|February 12, 2018
Development of orthogonal NISTmAb size heterogeneity control methodsAbigail Turner, Katharina Yandrofski, Srivalli Telikepalli, et al.
Analytical and Bioanalytical Chemistry|February 8, 2018
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stabilityJohn E Schiel, Abby Turner, Trina Mouchahoir, et al.
Journal of Pharmaceutical Sciences|December 19, 2014
Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stressSrivalli Telikepalli, Ozan S Kumru, Jae Hyun Kim, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sortingSrivalli Telikepalli, Heather E Shinogle, Prem S Thapa, et al.
Journal of Pharmaceutical Sciences|January 14, 2020
Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in JapanAkiko Ishii-Watabe, Hiroko Shibata, Hiroyuki Suetomo, et al.
Pageof 1